Quest cuts 2023 COVID tests forecast amid continued slump in demand; Q4 profit plunges

The company performed 1.2 million molecular tests in the fourth quarter, down from 1.9 million in the third quarter and 5.4 million one year ago.

By Nick Paul Taylor • Feb. 3, 2023

BD raises full-year forecast, sees Q1 strength in pharmacy automation, pre-fillables

The company’s base businesses helped cushion the impact of declining COVID-19 testing demand.

By Susan Kelly • Feb. 2, 2023

Siemens Healthineers forecasts revenue growth to accelerate despite supply chain woes

Lower diagnostics revenue hurt sales in the three months ended Dec. 31.

By Nick Paul Taylor • Feb. 2, 2023

Boston Scientific gets Q4 boost from heart, urology sales

Following a series of significant acquisitions, the company said it expects net sales growth of about 5% to 7% in full-year 2023.

By Susan Kelly • Feb. 1, 2023

Edwards posts Q4 profit, reaffirms 2023 outlook as patients return

The heart valve specialist said it is optimistic that the healthcare environment will gradually improve this year.

By Susan Kelly • Feb. 1, 2023

Stryker expects 2023 growth despite 15% dip in Q4 net income

CEO Kevin Lobo said he expects new product launches and device orders will offset continued “macroeconomic volatility.”

By Elise Reuter • Feb. 1, 2023

GE HealthCare posts revenue growth in last quarter before spinoff on imaging, ultrasound units

The company benefitted from “robust end-market demand, improved pricing, and easing supply chain pressures” in the period.

By Peter Green • Jan. 30, 2023

ResMed quarterly revenue beats estimates as supply chain woes ease

Demand for CPAP devices and respirators remains strong as the company expects to pick up additional market share from rival Philips, and demand grows for its medical SaaS products.

By Susan Kelly • Jan. 27, 2023

Intuitive Q4 profit slips on costs to boost share of robotic surgery market

The investment in innovation comes as Intuitive tries to maintain its dominant position in the face of rivals including Johnson & Johnson and Medtronic.

By Nick Paul Taylor • Jan. 25, 2023

3M’s healthcare unit Q4 earnings drop on nurse shortages, falling hospital budgets

Elective healthcare procedure volumes were about 90% of pre-COVID levels.

By Nick Paul Taylor • Jan. 25, 2023

J&J sees Abiomed adding to revenue in 2024; Q4 sales drop

Foreign-exchange fluctuations helped curb revenue in the period.

By Peter Green • Jan. 24, 2023

Medtech companies start 2023 on ‘optimistic’ note amid earnings forecasts, staffing: J.P. Morgan

Executive comments at the healthcare conference in San Francisco suggest companies expect staffing pressures and supply constraints to improve in 2023, analysts say.

By Elise Reuter • Jan. 17, 2023

Intuitive forecasts 12%-16% growth in procedures in 2023 even as da Vinci robot sales slowed in Q4

For hospitals that have been reporting growth in robotic procedures, “da Vinci is a relative priority in their capital budgets,” the company said.

By Elise Reuter • Jan. 11, 2023

Guardant Health posts revenue growth in Q4 on higher clinical testing volumes

The oncology diagnostics company’s preliminary results beat analyst estimates.

By Nick Paul Taylor • Jan. 10, 2023

Dexcom forecasts 2023 revenue to rise as much as 20% on G7 launch

Sales are expected to reach $3.35 billion to $3.49 billion for the full year.

By Elise Reuter • Jan. 9, 2023

The 10 biggest medtech stories of 2022

MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.

By MedTech Dive staff • Dec. 3, 2022

Teleflex launches another round of restructuring

Rising costs are pushing the device maker to incur restructuring liabilities of $31 million to $40 million.

By Elise Reuter • Nov. 23, 2022

Medtronic lowers full-year forecast, citing drop in procedure growth

A slower-than-expected recovery in certain procedures, including TAVR and spinal cord stimulation, curbed quarterly profit and revenue.

By Elise Reuter • Nov. 22, 2022

Q3 Earnings Wrap: Bumpy time for medtech with inflation, FX, supply woes

Macroeconomic pressures were a persistent theme for the industry, with workforce reductions a part of the fallout for some companies.

By Susan Kelly • Nov. 21, 2022

BD says inflationary pressures persist; COVID-19 test sales plunge

Revenue at the company’s medical segment grew in the fourth quarter, helped by the acquisition of pharmacy automation company Parata. 

By Elise Reuter • Nov. 10, 2022

Siemens Healthineers beats sales forecasts on imaging demand as diagnostic pressures prompt restructuring

Siemens Healthineers is revamping its diagnostics unit after concluding that “external headwinds [are] outweighing operational improvements.”

By Nick Paul Taylor • Nov. 9, 2022